Todd C. Brady M.D., Ph.D.
|Age||Total Calculated Compensation||This person is connected to 89 board members in 13 different organizations across 14 different industries.|
See Board Relationships
Dr. Todd C. Brady, M.D., Ph.D., has been the Chief Executive Officer and President of Aldeyra Therapeutics, Inc. since January 2012. Dr. Brady is a Co-Founder of Phenome Sciences and serves as its Chief Executive Officer. He serves as a Senior Advisor at Solidus Investment Co., Ltd. He served as Principal Financial and Accounting Officer of Aldeyra Therapeutics, Inc. He was an Entrepreneur-In-Residence at Domain Associates, L.L.C since 2013. He joined Domain Associates ...
One Palmer SquarePhone: 609-683-5656
Princeton, New Jersey 08542
Board Members Memberships*
Chief Executive Officer, President, Director and Member of Stock Option Committee
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Duke University Medical Center
The Graduate School, Duke University
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.